Patents Assigned to CELL THERAPY LIMITED
  • Mesodermal killer (MK) cell
    Patent number: 12527868
    Abstract: The invention relates to mesodermal killer (MK) cells and their use in therapy, especially for the treatment of cancer.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: January 20, 2026
    Assignee: Cell Therapy Limited
    Inventors: Lee Chapman, Sabena Sultan
  • Immuno-modulatory progenitor (IMP) cell
    Patent number: 12029763
    Abstract: The invention relates to immuno-modulatory progenitor (IMP) cells and their use in therapy.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: July 9, 2024
    Assignee: CELL THERAPY LIMITED
    Inventors: Ajan Reginald, Martin John Evans, Sabena Sultan
  • Platelet lysate gel
    Patent number: 11304981
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: April 19, 2022
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Progenitor cells of mesodermal lineage
    Patent number: 10829739
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: November 10, 2020
    Assignee: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Trevor Reginald, Ina Laura Pieper
  • Progenitor cells of mesodermal lineage
    Patent number: 10472609
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 12, 2019
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • Immuno-oncology mesodermal progenitor (ioMP) cell
    Patent number: 10316291
    Abstract: The invention relates to immuno-oncology mesodermal progenitor (ioMP) cells and their use in therapy.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 11, 2019
    Assignee: Cell Therapy Limited
    Inventors: Ajan Reginald, Sabena Sultan, Martin John Evans
  • Platelet lysate gel
    Patent number: 10117898
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: November 6, 2018
    Assignee: Cell Therapy Limited
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • PROGENITOR CELLS OF MESODERMAL LINEAGE
    Publication number: 20150071886
    Abstract: The invention relates to progenitor cells of mesodermal lineage and their use in therapy.
    Type: Application
    Filed: July 6, 2012
    Publication date: March 12, 2015
    Applicant: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper
  • PLATELET LYSATE GEL
    Publication number: 20140335195
    Abstract: The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
    Type: Application
    Filed: November 23, 2012
    Publication date: November 13, 2014
    Applicant: CELL THERAPY LIMITED
    Inventors: Thomas Averell Houze, Martin John Evans, Ajan Reginald, Ina Laura Pieper